This invention relates to a method of covalently bind ing substances to plastic materials and to immunological determinations employing such bound substances.
In radioimmunoassay or competitive protein binding radioassay, the compound to be measured, generally the antigen, is allowed to compete with a similar or a chem ically related radioactive compound for a limited num ber of binding sites on the antibodies or on the specific binding proteins. The antibody bound radioactive la beled compound is then separated form the free labeled compound and measured. Separation methods currently. used, for example, electrophoresis, gel filtration, precip itation of free antigen with charcoal and precipitation of bound antigen with salt or another antibody, are often time consuming, complicated and do not give clear cut separation. Fixation of antibodies to the wall of a test tube enables the separation of the bound and free anti gen by simple decantation.
It is an object of this invention to provide covalently bound substances to plastic materials which are useful in radioimmunoassays.
It is a further object of this invention to provide a method of covalently binding substances to plastic ma terials.
It is another object of this invention to provide a method of radioassaying for biological substances which includes using covalently bound immunological counterparts, such as antibodies.
It is an additional object to provide a radioassay ma terial comprised of covalently bound substances to plas tic materials.
These and other related objects are achieved as foll lows. Antibodies, specific binding proteins or other protein material such as enzymes are covalently linked through their amino and other reactive groups to active aldehyde groups of aliphatic dialdehydes, such as glu taraldehyde, that have been previously polymerized on the inside surface of a plastic material, such as a plastic test tube, for example a polypropylene or a polyethyl ene test tube.
The polymerized glutaraldehyde may in turn be at tached to aliphatic primary amines of the general for mula CH3-(CH2)n-NH2 where n is an integer of from 5 to 20, preferably 18, or aliphatic diamines of the general formula CH3-(CH2)-NH-(CH2)-NH2 where n and m are integers of from 3 to 20, preferably where n is 18 and m is 3. In this embodiment of the invention, prior to reaction with glutaraldehyde the plastic material is heated in a solution of the amine or diamine (as defined above) at temperatures above 50° C., preferably at 90 C. The excess amine or diamine is washed away and the plastic is treated with a solution of glutaraldehyde at room temperature, or a slightly elevated temperature, for example at 56' C. for a period of time extending from 1 to 2 hours to l to 2 days. Thus it is within the scope of the method of this invention that glutaralde hyde is polymerized directly on the inside surface of a plastic material such as a plastic test tube with or with out prior treatment with an aliphatic amine or diamine. In order to carry out a radioassay a mixture contain ing buffer, labeled antigen or analogues and unlabeled antigen or analogues from a biological fluid, such as serum, or from a standard solution is incubated in a plastic test tube with antibody or other specific binding protein covalently bound to the inside surface of the test tube according to the method of this invention. After a suitable incubation period the free antigen is removed rapidly and simply by decantation, leaving no time for readjustment of the established equilibrium. The radio active antigen bound to the test tube is counted after the tube has been rinsed with buffer. The entire procedure is simple, rapid and no special skill is required.
It is believed that there is a self-polymerization of the aldehyde material on the surface of the plastic followed by a Schiff base-type coupling of the protein to the active aldehyde group.
The term "immunological counterpart' used herein denotes either an antigen or an antibody which reacts specifically with the corresponding antibody or antigen. The term "biological substance' used herein denotes a material of biological origin such as an antigen, anti body or enzyme, all of which being capable of chemi cally reacting with an aldehyde group. Unreacted amino groups present in the protein chains of most biological substances provide such chemically reactive groups.
TREATMENT OF PLASTIC TUBES An aqueous solution of glutaraldehyde is dispensed into a plastic test tube, for example a polypropylene or polyethylene test tube, and is allowed to remain in con tact with the inner surface of the test tube at room tem perature or slightly elevated temperature, for example 56° C., for a period of time such as 1 to 2 hours to 1 to 2 days. The glutaraldehyde polymerizes on the surface of the plastic and forms a thin layer of polymer on the inner surface of the plastic test tube with a large number of active aldehyde groups that can react covalently with primary amino groups of antibodies or proteins.
The polymerization of glutaraldehyde occurs at a wide pH range, namely from 3 to 10. Also, the glutaral dehyde solution polymerizes on plastic surfaces over a wide range of aldehyde concentration, namely 0.1, 0.2, 0.5, 1 or 2% glutaraldehyde. The amount of glutaralde hyde polymer and consequently the number of active aldehyde groups on the plastic surface can be increased or decreased by varying the concentration of the alde hyde solution, incubation time and temperature. Excess active aldehyde groups on the plastic surface that are not used up in consequent protein coupling can be blocked by reacting with compounds having primary amino groups such as monoethanolamine or lysine.
After the glutaraldehyde is polymerized on the sur face of the test tube, the aldehyde solution is removed by aspiration and the tube is washed thoroughly with deionized water. Tubes thus prepared are ready for use in a radioassay comprising protein or antibody cou pling. The aldehyde treated tubes are very stable and retain their ability to couple protein even after washings with concentreated salt solutions and detergents. An antibody solution of from 1 to 100 g of protein per ml of buffer is dispensed into a glutaraldehyde treated tube and allowed to remain in contact with the treated surface at 4 C. for 15 hours. The antibody solution is removed by aspiration and, after rinsing the tube thor oughly with buffer, it can be used immediately for ra dioimmunoassay or stored for months until use. The antibody coated tubes are excellent for radioimmunoas say to give reproducible results, because (1) the anti body covalently coupled to the test tube is very stable and cannot be washed away (2) the antibodies so cou pled to the wall retain their immunological reactivity for a long period of time and (3) Chem., 193,265 (1951) and the fractions diluted to 15ug per ml of 0.1 M phosphate buffer pH 7.0. (6) Vortex mix. Incubate at room temperature for 60 minutes.
(7) Decant and discard the reaction mixture, remov ing the last drop of liquid by inverting the vials over a paper towel. Prior art disclosures thus include the binding of hepa rin to polypropylene tubes previously treated with ali phatic diamines, followed by surface treatment with glutaraldehyde, the cross-linking of proteins with glu taraldehyde for use in the preparation of immunoad sorbents, and the use of antibody-coated plastic tubes without aldehyde pretreatment in radioimmunoassay. There is no report of the use of plastic tubes, coated with polymerized glutaraldehyde with or without ali phatic amine polymers prior to application of antibody, in radioimmunoassay procedures.
It is an additional object of this invention to provide a method of determining the degree of unsaturation of carriers of biologically active compounds in biological fluids. For example, to measure unsaturated binding capacity of hormone binding globulin and other pro teins. In one aspect, this invention relates to an im proved method for removing free thyroid hormones from mixtures containing hormones in a free state and hormones which are bound to hormone binding globu lin and other proteins.
Various diagnostic tests are known in the art for determining thyroid function. These tests include the basal metabolism test, the thyroid uptake test and vari ous colorimetric and chemical procedures for determin ing the level of thyroxine iodine in the blood. Among the most accurate tests available are the diagnostic tests which utilize radioisotope labeled hormone to indi rectly determine the level of thyroid hormones, thyrox ine and triiodothyronine present in body fluids. Specifi cally, these tests include a test commonly referred to as the T-3 uptake test which measures the unsaturated binding capacity of thyrobinding globulin and other proteins within a body fluid such as blood.
T-3 uptake tests include the steps of adding the radio isotope labeled hormone to a solution containing a sam ple of hormone produced within the body and thyro binding globulin (TBG), separating the resulting thyro binding globulin containing bound hormone from the resulting unbound hormone, and counting the radioac tivity of either the bound or unbound hormone. This counting procedure will indirectly indicate the amount 8 of endogenous hormone which is bound to the natural globulin and protein binding sites within the blood.
Thus, the T-3 uptake test depends for its accuracy upon the efficient separation between the bound and The major disadvantages of the currently available separation methods described above are:
(a) They require manual addition of bound-free sepa rating agents such as silicate tablets, resin sponges, or As a result of (a), (b), (c) and (d) present systems are not readily automatable.
Therefore, one object of this invention is to provide an improved diagnostic test for indirectly determining the level of thyroid hormone in a body fluid by detect ing the degree of unsaturation of thyrobinding globulin (TBG).
Another object of this invention is to provide an improved method of separating thyroid hormone bound to thyroidbinding globulin and other proteins from unbound thyroid hormones.
According to the invention, the separation of the free hormones from hormones bound to natural binding sites (thyrobinding globulin and other proteins) in a diagnos tic test is carried out by attachment of the free hor mones to hormone specific protein immobilized on in soluble supports and results in a highly efficient, simple, fast and reproducible result. This separation is con ducted by aspiration or decantation. Either the supernatant fluid or the immobilized hormone specific protein can be counted in a scintillation well counter; however, it is preferred that the immobilized hormone specific protein be counted. The particularly novel aspect of this invention is the use of an antibody (hormone specific protein) for deter mining the degree of unsaturation of a carrier of a bio logically active compound in a biological fluid. For this purpose the antibody can be immobilized on any ar trecognized support means. Such support means would include, for example, adsorbtion to the walls of a plastic test tube, ion exchange chromatography resin, precipi tation with polyethylene glycol, a second antibody or ammonium sulfate, and a gel sieve. A useful support means, as described more fully hereinbefore, is the wall of a plastic test tube treated with glutaraldehyde to which is coupled the antibody.
In operation, immobilized hormone specific protein is exposed to patient sample in a buffer containing radio actively labeled hormone. For example, a hormone specific protein such as anti-triiodothyronine gamma globulin, can be coupled to the walls of a glutaralde hyde treated plastic test tube. Patient sample, preferably serum, is added to the tube followed by a buffer contain ing radioactively labeled hormone such as triiodothyro 4, 225, 784 nine. The solution is mixed for 5 seconds followed by incubation for at least 15 minutes, but preferably 1 hour. In this example, unsaturation of thyrobinding globu lin was detected using anti-T-3 gamma globulin im mobilized on the walls of polypropylene test tubes. The radioisotope (I25) labeled hormone was triiodothyro nine. Patient serum sample size was 0.02 milliliter and the buffer was 0.05 M barbital, pH 8.0. Serum samples from hypothyroid, normal and hyperthyroid patients were incubated for 60 minutes at room temperature.
After the incubation, the buffer was aspirated and tubes counted. Comparison to counts obtained using a stand ardizing serum calibrated with an inorganic silicate gave the following results:
Hypothyroid 27%
Normal 39.1% Hyperthyroid 55%
The above results clearly indicate that use of anti-T-3 gamma globulin immobilized on the walls of an insolu ble support, such as polypropylene test tubes is capable, in combination with T-3 I125 in barbital buffer, of distin guishing between hypothyroid, normal and hyperthy roid patient samples. EXAMPLE 4 In this example, unsaturation of thyrobinding globu lin was detected using anti-thyroxine gamma globulin immobilized on the walls of polypropylene test tubes. The radioisotope (I125) labeled hormone was thyroxine (T-4). Patient serum sample size was 0.02 milliliter and the buffer was 0.05 M barbital, pH 8.0. Serum samples from hypothyroid, normal and hyperthyroid patients were incubated for 60 minutes at room temperature. After the incubation, the buffer was aspirated and tubes counted. Comparison to counts obtained using a stand ardizing serum calibrated with an inorganic silicate gave the following results:
Hypothyroid 22
Normal 39
Hyperthyroid 62
The above results clearly indicate that use of anti-T-4 gamma globulin immobilized on the walls of an insolu ble support, such as polypropylene test tubes is capable, in combination with T-4 I125 in barbital buffer, of distin guishing between hypothyroid, normal and hyperthy roid patient samples. The results indicated an extremely low coefficient of 30 variation and that use of hormone specific protein, espe cially when immobilized, yields highly reproducible
